Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

154.93
-0.4500-0.29%
Post-market: 154.930.00000.00%19:58 EDT
Volume:8.31M
Turnover:1.28B
Market Cap:373.36B
PE:17.24
High:155.90
Open:155.80
Low:153.44
Close:155.38
Loading ...

J&J CEO Says Healthcare Companies Should Partner With the US Government to Mitigate Vulnerabilities in the Supply Chain

THOMSON REUTERS
·
15 Apr

J&J CEO, on Potential Pharma Tariffs, Says Plans to Make Sure Co Has Enough Manufacturing Capacity in the US to Be Able to Address Multiple Scenarios

THOMSON REUTERS
·
15 Apr

J&J CEO Says "Not Tariffs, but Tax Policy" Is the Most Effective Way to Build Manufacturing Capacity in the US for Medical Devices and Pharmaceuticals

THOMSON REUTERS
·
15 Apr

J&J Exec Says Restructuring Program for Surgery Business Is Expected to Be Completed in 2027 With Cost Estimated at About $900 Mln

THOMSON REUTERS
·
15 Apr

J&J Exec Says Plan to Exit Certain Non Strategic Product Lines Globally & Optimize Select Sites Across the Network for Surgery Business

THOMSON REUTERS
·
15 Apr

Bank of America, Citigroup, Johnson & Johnson: Stocks to watch today

Quartz
·
15 Apr

Johnson & Johnson Shares Down 2.2% Premarket After Q1 Results

THOMSON REUTERS
·
15 Apr

Johnson & Johnson Q1 2025 Earnings: EPS Soars to $4.54, Revenue Hits $21.9 Billion, Both Surpass Estimates

GuruFocus
·
15 Apr

Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke

TipRanks
·
15 Apr

Johnson & Johnson Tops Earnings Estimates and Boosts Outlook. The Stock Slips. -- Barrons.com

Dow Jones
·
15 Apr

US STOCKS-US stock futures muted as investors assess scope for more tariff exemptions

Reuters
·
15 Apr

Johnson & Johnson CEO warns US tariffs may disrupt drug supply

Reuters
·
15 Apr

Trade, Earnings Nudge Wall Street Higher Pre-Bell; Asia, Europe Gain

MT Newswires
·
15 Apr

Johnson & Johnson provides 2027/2028 sales view of Innovative Medicine assets

TIPRANKS
·
15 Apr

BRIEF-Johnson & Johnson CFO Joe Wolk On Tariffs On Imported Pharmaceuticals Says I Don't Want To Speculate, I Want The Process To Play Out - CNBC Interview

Reuters
·
15 Apr

Johnson & Johnson CFO Joe Wolk on Tariffs on Imported Pharmaceuticals: I Don't Want to Speculate, I Want the Process to Play Out - CNBC Interview

THOMSON REUTERS
·
15 Apr

Stocks that benefit from chaos are helping a husband-and-wife investing duo beat the competition

Dow Jones
·
15 Apr

Johnson & Johnson Shares Rise On Q1 Profit And Revenue Beat And Raised Guidance -- MarketWatch

Dow Jones
·
15 Apr

Johnson & Johnson anticipates 2025 milestones driving long-term value creation

TIPRANKS
·
15 Apr

Johnson & Johnson's Q1 Adjusted Earnings, Revenue Rise; Reiterates 2025 Adjusted Earnings Guidance

MT Newswires Live
·
15 Apr